{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T02:26:09Z","timestamp":1788661569096,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS111553"],"award-info":[{"award-number":["R01NS111553"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RFNS113881"],"award-info":[{"award-number":["RFNS113881"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.neulet.2023.137512","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T15:30:35Z","timestamp":1696606235000},"page":"137512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Systemic administration of NIS-lncRNA antisense oligonucleotide alleviates neuropathic pain"],"prefix":"10.1016","volume":"817","author":[{"given":"Tolga","family":"Berkman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Korban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-3272","authenticated-orcid":false,"given":"Yuan-Xiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neulet.2023.137512_b0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2023.137512_b0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pnpbp.2019.04.006","article-title":"The silent epidemic of chronic pain in older adults","volume":"93","author":"Domenichiello","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psych."},{"issue":"4","key":"10.1016\/j.neulet.2023.137512_b0015","doi-asserted-by":"crossref","first-page":"e191532","DOI":"10.1001\/jamanetworkopen.2019.1532","article-title":"The cost of pain","volume":"2","author":"Smith","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neulet.2023.137512_b0020","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418776932","article-title":"Antisense oligonucleotides in neurological disorders","volume":"11","author":"Wurster","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"6","key":"10.1016\/j.neulet.2023.137512_b0025","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","article-title":"Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases","volume":"94","author":"Schoch","year":"2017","journal-title":"Neuron"},{"issue":"18","key":"10.1016\/j.neulet.2023.137512_b0030","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.neulet.2023.137512_b0035","doi-asserted-by":"crossref","first-page":"e153563","DOI":"10.1172\/JCI153563","article-title":"A nerve injury-specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression","volume":"132","author":"Du","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.neulet.2023.137512_b0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bja.2022.09.027","article-title":"Effect of intrathecal NIS-lncRNA antisense oligonucleotides on neuropathic pain caused by nerve trauma, chemotherapy, or diabetes mellitus","volume":"130","author":"Wen","year":"2022","journal-title":"Br. J. Anaesth."},{"issue":"13","key":"10.1016\/j.neulet.2023.137512_b0045","doi-asserted-by":"crossref","first-page":"e2004515","DOI":"10.1002\/advs.202004515","article-title":"Downregulation of a dorsal root ganglion-specifically enriched long noncoding RNA is Required for neuropathic pain by negatively regulating RALY-triggered Ehmt2 expression","volume":"8","author":"Pan","year":"2021","journal-title":"Adv Sci (weinh)"},{"issue":"1","key":"10.1016\/j.neulet.2023.137512_b0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s13311-020-00931-5","article-title":"CREB participates in paclitaxel-induced neuropathic pain genesis through transcriptional activation of dnmt3a in primary sensory neurons","volume":"18","author":"Yang","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.neulet.2023.137512_b0055","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bja.2020.10.032","article-title":"Eukaryotic initiation factor 4 gamma 2 contributes to neuropathic pain through downregulation of Kv1.2 and the mu opioid receptor in mouse primary sensory neurones","volume":"126","author":"Zhang","year":"2021","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.neulet.2023.137512_b0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/j.pain.0000000000001074","article-title":"Antisense oligonucleotides selectively suppress target RNA in nociceptive neurons of the pain system and can ameliorate mechanical pain","volume":"159","author":"Mohan","year":"2018","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.neulet.2023.137512_b0065","first-page":"106","article-title":"BIX01294, a G9a inhibitor, alleviates nerve injury-induced pain hypersensitivities during both development and maintenance periods","volume":"6","author":"Liang","year":"2019","journal-title":"Transl Perioper Pain Med"},{"issue":"2","key":"10.1016\/j.neulet.2023.137512_b0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/j.pain.0000000000001405","article-title":"Contribution of dorsal root ganglion octamer transcription factor 1 to neuropathic pain after peripheral nerve injury","volume":"160","author":"Yuan","year":"2019","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neulet.2023.137512_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/j.pain.0000000000002673","article-title":"E74-like factor 1 contributes to nerve trauma-induced nociceptive hypersensitivity via transcriptionally activating matrix metalloprotein-9 in dorsal root ganglion neurons","volume":"164","author":"Zhang","year":"2022","journal-title":"Pain"},{"issue":"13","key":"10.1016\/j.neulet.2023.137512_b0080","doi-asserted-by":"crossref","first-page":"1902402","DOI":"10.1002\/advs.201902402","article-title":"N(6)-methyladenosine demethylase FTO contributes to neuropathic pain by stabilizing G9a expression in primary sensory neurons","volume":"7","author":"Li","year":"2020","journal-title":"Adv Sci (weinh)"},{"key":"10.1016\/j.neulet.2023.137512_b0085","doi-asserted-by":"crossref","first-page":"14712","DOI":"10.1038\/ncomms14712","article-title":"DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons","volume":"8","author":"Zhao","year":"2017","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.neulet.2023.137512_b0090","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nn.3438","article-title":"A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons","volume":"16","author":"Zhao","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neulet.2023.137512_b0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuron.2006.09.021","article-title":"Mechanisms of neuropathic pain","volume":"52","author":"Campbell","year":"2006","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neulet.2023.137512_b0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/02652040500162766","article-title":"Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain","volume":"22","author":"Kilic","year":"2005","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.neulet.2023.137512_b0105","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0304-3959(99)00135-9","article-title":"Unexplained peculiarities of the dorsal root ganglion","volume":"Suppl 6","author":"Devor","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2023.137512_b0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8069-4-10","article-title":"Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies","volume":"4","author":"Jimenez-Andrade","year":"2008","journal-title":"Mol. Pain"},{"issue":"17","key":"10.1016\/j.neulet.2023.137512_b0115","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-customized oligonucleotide therapy for a rare genetic disease","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.neulet.2023.137512_b0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/nat.2018.0720","article-title":"Dose-dependent lowering of mutant huntingtin using antisense oligonucleotides in huntington disease patients","volume":"28","author":"van Roon-Mom","year":"2018","journal-title":"Nucleic Acid Ther."},{"issue":"7","key":"10.1016\/j.neulet.2023.137512_b0125","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/j.pain.0000000000001212","article-title":"Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity","volume":"159","author":"Illias","year":"2018","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.neulet.2023.137512_b0130","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jpain.2014.01.492","article-title":"Contribution of chemokine CCL2\/CCR2 signaling in the dorsal root ganglion and spinal cord to the maintenance of neuropathic pain in a rat model of lumbar disc herniation","volume":"15","author":"Zhu","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.neulet.2023.137512_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107581","article-title":"Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential","volume":"212","author":"Jiang","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.neulet.2023.137512_b0140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1471-4159.2007.04969.x","article-title":"Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons","volume":"104","author":"Jung","year":"2008","journal-title":"J. Neurochem."},{"issue":"13","key":"10.1016\/j.neulet.2023.137512_b0145","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1523\/JNEUROSCI.3623-08.2009","article-title":"JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain","volume":"29","author":"Gao","year":"2009","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.neulet.2023.137512_b0150","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.1331358100","article-title":"Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2","volume":"100","author":"Abbadie","year":"2003","journal-title":"PNAS"},{"issue":"15","key":"10.1016\/j.neulet.2023.137512_b0155","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1523\/JNEUROSCI.5986-10.2011","article-title":"CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury","volume":"31","author":"Van","year":"2011","journal-title":"J. Neurosci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023004718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023004718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:10:35Z","timestamp":1736359835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394023004718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":31,"alternative-id":["S0304394023004718"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137512","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic administration of NIS-lncRNA antisense oligonucleotide alleviates neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"137512"}}